Amicus Therapeutics Inc (NASDAQ: FOLD) on Monday, plunged -0.14% from the previous trading day, before settling in for the closing price of $14.27. Within the past 52 weeks, FOLD’s price has moved between $5.51 and $14.36.
Annual sales at Healthcare sector company grew by 34.10% over the past five years. The company achieved an average annual earnings per share of 89.68%. With a float of $303.11 million, this company’s outstanding shares have now reached $308.50 million.
Amicus Therapeutics Inc (FOLD) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Amicus Therapeutics Inc is 2.00%, while institutional ownership is 102.89%. The most recent insider transaction that took place on Dec 19 ’25, was worth 363,380. In this transaction Chief People Officer of this company sold 25,642 shares at a rate of $14.17, taking the stock ownership to the 245,690 shares. Before that another transaction happened on Dec 19 ’25, when Company’s Officer proposed sale 25,642 for $10.89, making the entire transaction worth $279,241.
Amicus Therapeutics Inc (FOLD) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.09 earnings per share (EPS) for the period topping the consensus outlook (set at 0.09) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
Amicus Therapeutics Inc (NASDAQ: FOLD) Trading Performance Indicators
Amicus Therapeutics Inc (FOLD) is currently performing well based on its current performance indicators. A quick ratio of 2.09 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.36. Likewise, its price to free cash flow for the trailing twelve months is 454.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.27 in one year’s time.
Technical Analysis of Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (NASDAQ: FOLD) saw its 5-day average volume 14.58 million, a negative change from its year-to-date volume of 23.27 million. As of the previous 9 days, the stock’s Stochastic %D was 73.92%.
During the past 100 days, Amicus Therapeutics Inc’s (FOLD) raw stochastic average was set at 98.51%, which indicates a significant increase from 97.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was lower than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.52, while its 200-day Moving Average is $7.91. Nevertheless, the first resistance level for the watch stands at $14.27 in the near term. At $14.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.33. If the price goes on to break the first support level at $14.22, it is likely to go to the next support level at $14.18. Assuming the price breaks the second support level, the third support level stands at $14.16.
Amicus Therapeutics Inc (NASDAQ: FOLD) Key Stats
Market capitalization of the company is 4.41 billion based on 308,534K outstanding shares. Right now, sales total 528,300 K and income totals -56,110 K. The company made 169,060 K in profit during its latest quarter, and 17,310 K in sales during its previous quarter.
